Answers are grounded in this paper and cite their sources.
The HypoCOMPaSS multi-centre trial achieved improvement in hypoglycaemia awareness and 20-fold reduction in severe hypoglycaemia (SH) in a cohort with long-standing type 1 diabetes (T1D). All participants received 'my hypo compass' (MHC) brief structured psycho-educational intervention in addition to optimisation of insulin delivery/glucose monitoring. In this 24-week, prospective, single-centre feasibility RCT, we piloted MHC as a sole intervention in comparison to standard clinical care alone (CON).
No takes yet. Share an insight, caveat, or question.
Bashir et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: